Form 4 for TRDA Entrada Therapeutics, Inc.
Accepted 2024-07-10 00:00:00 ET · period of report 2024-07-08 · accession 0001689375-24-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-10 | 2024-07-08 | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale | $14.95 | -1,758 | 81.4K | -2% | -$26.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-08 | S | D | 1,758 | $14.95 | 81,412 | D | — | — |